UK MHRA To Explore Innovative Ways Of Setting Quality Standards For Biological Medicines
Executive Summary
The UK MHRA has analyzed the responses to a consultation on its proposed strategy for developing pharmacopeial standards for biological medicines and says it now plans to work more closely with stakeholders to look at unmet needs, new innovative approaches to standard-setting, and build closer relations with other organizations at home and abroad.